0001654954-23-009275.txt : 20230717 0001654954-23-009275.hdr.sgml : 20230717 20230717160747 ACCESSION NUMBER: 0001654954-23-009275 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 EFFECTIVENESS DATE: 20230717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-487144 FILM NUMBER: 231091711 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 D 1 primary_doc.xml X0708 D LIVE 0001101026 Zivo Bioscience, Inc. 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 248-452-9866 NEVADA HEALTH ENHANCEMENT PRODUCTS INC WESTERN GLORY HOLE INC Corporation true 2023 John B. Payne 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 Executive Officer Keith R. Marchiando 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 Executive Officer Allison A. Cornell 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 Director Christopher D. Maggiore 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 Director Nola E. Masterson 21 E. Long Lake Road Suite 100 Bloomfield Hills MI MICHIGAN 48304 Director Biotechnology Decline to Disclose 06b false 2023-06-30 false true true false 0 Maxim Group LLC 120708 None None 300 Park Ave 16th Floor New York NY NEW YORK 10022 NY NEW YORK 3999960 3999960 0 Warrants to purchase shares of common stock were issued for no separate consideration in connection with a sale of common stock and prefunded warrants to an investor. Excludes potential proceeds totaling up to $8,389,528 to be received upon exercise. false 1 279998 0 0 Zivo Bioscience, Inc. /s/ Keith R. Marchiando Keith R. Marchiando Chief Financial Officer 2023-07-17